TLR4 and COVID-19: In contrast to macrophages and endothelial cells, alveolar cell (in particular type 1) show generally very low levels of TLRs [11], suggesting that, primarily, the activation of TLR4 and TLR2 on macrophages and endothelial cells may be responsible for the excessive disturbances during severe and critical COVID-19 stages.